share_log
Reuters ·  May 7 17:07
Akari Therapeutics PLC - Expects Expenses Related to Reduction-in-Force to Be in Range of About $3.1 Mln to $3.2 Mln
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment